GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Total Stockholders Equity

Alto Neuroscience (Alto Neuroscience) Total Stockholders Equity : $193.10 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Total Stockholders Equity?

Alto Neuroscience's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $193.10 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Alto Neuroscience's Book Value per Share for the quarter that ended in Mar. 2024 was $7.18. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Alto Neuroscience's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.05.

Alto Neuroscience Total Stockholders Equity Historical Data

The historical data trend for Alto Neuroscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Total Stockholders Equity Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Total Stockholders Equity
-12.48 -38.41 -71.67

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial -38.41 - -61.10 -71.67 193.10

Alto Neuroscience  (NYSE:ANRO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Alto Neuroscience's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(193.104-0)/26.884
=7.18

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Alto Neuroscience's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.201 + 8.812) / 193.104
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Total Stockholders Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024